| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | GRM3 |
| Uniprot No | Q14832 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-879aa |
| 氨基酸序列 | MKMLTRLQVLTLALFSKGFLLSLGDHNFLRREIKIEGDLVLGGLFPINEKGTGTEECGRINEDRGIQRLEAMLFAIDEINKDDYLLPGVKLGVHILDTCSRDTYALEQSLEFVRASLTKVDEAEYMCPDGSYAIQENIPLLIAGVIGGSYSSVSIQVANLLRLFQIPQISYASTSAKLSDKSRYDYFARTVPPDFYQAKAMAEILRFFNWTYVSTVASEGDYGETGIEAFEQEARLRNICIATAEKVGRSNIRKSYDSVIRELLQKPNARVVVLFMRSDDSRELIAAASRANASFTWVASDGWGAQESIIKGSEHVAYGAITLELASQPVRQFDRYFQSLNPYNNHRNPWFRDFWEQKFQCSLQNKRNHRRVCDKHLAIDSSNYEQESKIMFVVNAVYAMAHALHKMQRTLCPNTTKLCDAMKILDGKKLYKDYLLKINFTAPFNPNKDADSIVKFDTFGDGMGRYNVFNFQNVGGKYSYLKVGHWAETLSLDVNSIHWSRNSVPTSQCSDPCAPNEMKNMQPGDVCCWICIPCEPYEYLADEFTCMDCGSGQWPTADLTGCYDLPEDYIRWEDAWAIGPVTIACLGFMCTCMVVTVFIKHNNTPLVKASGRELCYILLFGVGLSYCMTFFFIAKPSPVICALRRLGLGSSFAICYSALLTKTNCIARIFDGVKNGAQRPKFISPSSQVFICLGLILVQIVMVSVWLILEAPGTRRYTLAEKRETVILKCNVKDSSMLISLTYDVILVILCTVYAFKTRKCPENFNEAKFIGFTMYTTCIIWLAFLPIFYVTSSDYRVQTTTMCISVSLSGFVVLGCLFAPKVHIILFQPQKNVVTHRLHLNRFSVSGTGTTYSQSSASTYVPTVCNGREVLDSTTSSL |
| 预测分子量 | 98,8 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于GRM3重组蛋白的3篇参考文献的简要概括：
1. **《Expression and functional characterization of recombinant metabotropic glutamate receptor 3 (GRM3) in mammalian cells》**
- 作者：Smith A, et al.
- 摘要：该研究在HEK293细胞中成功表达了GRM3重组蛋白，并验证了其与G蛋白偶联的信号传导功能。通过荧光标记和钙离子流检测，证明了重组GRM3对谷氨酸的剂量依赖性响应，为药物筛选提供了工具。
2. **《Structural insights into GRM3 extracellular domain using recombinant protein crystallography》**
- 作者：Zhang L, et al.
- 摘要：研究者利用昆虫细胞表达系统纯化GRM3的胞外结构域重组蛋白，并通过X射线晶体学解析其三维结构，揭示了谷氨酸结合位点的关键氨基酸残基，为靶向GRM3的药物设计提供了结构基础。
3. **《GRM3 polymorphisms and schizophrenia: Functional analysis via recombinant protein models》**
- 作者：Brown K, et al.
- 摘要：通过在大肠杆菌中表达GRM3重组蛋白片段，分析了精神分裂症相关SNP位点(如rs6465084)对蛋白稳定性和配体结合能力的影响，发现特定突变会显著降低受体活性，提示遗传变异与疾病风险的关联。
4. **《Optimized purification of recombinant GRM3 for in vitro agonist screening》**
- 作者：Chen R, et al.
- 摘要：开发了一种基于亲和层析和尺寸排阻色谱的GRM3重组蛋白高效纯化方案，验证了纯化蛋白在SPR(表面等离子体共振)技术中的配体结合活性，成功应用于新型激动剂的筛选。
注：上述文献为示例性概括，实际引用时需根据具体研究核实准确性。
**Background of GRM3 Recombinant Protein**
GRM3 (glutamate metabotropic receptor 3) is a G protein-coupled receptor (GPCR) that belongs to the group III metabotropic glutamate receptor family. It plays a critical role in modulating synaptic transmission and neuronal excitability by responding to glutamate, the primary excitatory neurotransmitter in the central nervous system (CNS). GRM3 is predominantly expressed in astrocytes and presynaptic neurons, where it regulates glutamate homeostasis, synaptic plasticity, and neuroprotection. Dysregulation of GRM3 has been implicated in neurological and psychiatric disorders, including schizophrenia, anxiety, and Alzheimer’s disease, making it a therapeutic target of interest.
Recombinant GRM3 protein is engineered through molecular cloning and heterologous expression systems (e.g., mammalian, insect, or bacterial cells) to produce a purified, functional form of the receptor for research applications. This protein typically retains key structural domains, including the large extracellular ligand-binding region, seven transmembrane helices, and intracellular signaling motifs. Its recombinant form enables detailed studies on receptor-ligand interactions, signal transduction mechanisms (e.g., cAMP inhibition or MAPK pathway activation), and the development of targeted drugs.
Researchers utilize GRM3 recombinant protein in assays such as ligand-binding studies, high-throughput drug screening, and structural analyses (e.g., X-ray crystallography or cryo-EM) to elucidate its conformational dynamics and therapeutic potential. Challenges in producing functional GRM3 include maintaining proper post-translational modifications (e.g., glycosylation) and ensuring membrane protein stability during purification. Advances in detergent solubilization, lipid nanodiscs, or fusion tags have improved its utility in vitro. Overall, GRM3 recombinant protein serves as a vital tool for decoding glutamate receptor biology and accelerating CNS drug discovery.
×
